Literature DB >> 2421894

Combination of bleomycin and mitomycin after failure of cisplatin and alkylating agent therapy in epithelial ovarian cancer.

F G Lawton, T J Perren, D M Luesley, C A Meanwell, K K Chan, J J Mould, G Blackledge.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1986        PMID： 2421894

Source DB:  PubMed          Journal:  Cancer Treat Rep        ISSN： 0361-5960


× No keyword cloud information.
  3 in total

1.  Detoxifying enzymes in human ovarian tissues: comparison of normal and tumor tissues and effects of chemotherapy.

Authors:  Z Djuric; V K Malviya; G Deppe; J M Malone; D L McGunagle; L K Heilbrun; B A Reading; W D Lawrence
Journal:  J Cancer Res Clin Oncol       Date:  1990       Impact factor: 4.553

2.  Phase II study of combination 4'-epidoxorubicin and mitomycin C in recurrent epithelial ovarian cancer.

Authors:  C Redman; F Lawton; N Stuart; M O'Brien; J Buxton; J Mould; A Chetiyawardana; M Crawford; M Patterson; V Sykes
Journal:  Cancer Chemother Pharmacol       Date:  1989       Impact factor: 3.333

3.  Response of patients in phase II studies of chemotherapy in ovarian cancer: implications for patient treatment and the design of phase II trials.

Authors:  G Blackledge; F Lawton; C Redman; K Kelly
Journal:  Br J Cancer       Date:  1989-04       Impact factor: 7.640
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.